MA (EU) number
(Invented) 
name
Strength
Pharmaceutical 
Form
Route of 
Administration
Immediate 
Packaging
Content 
(concentration)
Pack size
EU/1/20/1525/001
JCOVDEN
EU/1/20/1525/002
JCOVDEN
--
¹
--¹ 
1 dose (0.5 mL) contains:
--¹
--¹
Suspension for 
injection
Suspension for 
injection
Intramuscular 
use
Intramuscular 
use
vial (glass)
2.5 ml (5 doses)
vial (glass)
2.5 ml (5 doses)
10 multidose vials 
(50 doses) 
20 multidose vials 
(100 doses) 
Adenovirus type 26 encoding the SARS-CoV-2 spike glycoprotein* (Ad26.COV2-S), not less than 8.92 log₁₀ infectious units (Inf.U).
*
Produced in the PER.C6 TetR Cell Line and by recombinant DNA technology.
1/1
